BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37845228)

  • 1. Sleeping Beauty transposon mutagenesis identified genes and pathways involved in inflammation-associated colon tumor development.
    Shimomura K; Hattori N; Iida N; Muranaka Y; Sato K; Shiraishi Y; Arai Y; Hama N; Shibata T; Narushima D; Kato M; Takamaru H; Okamoto K; Takeda H
    Nat Commun; 2023 Oct; 14(1):6514. PubMed ID: 37845228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
    Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment.
    Huang K; Luo W; Fang J; Yu C; Liu G; Yuan X; Liu Y; Wu W
    BMC Cancer; 2023 Jan; 23(1):55. PubMed ID: 36647017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.
    Oshima H; Nakayama M; Han TS; Naoi K; Ju X; Maeda Y; Robine S; Tsuchiya K; Sato T; Sato H; Taketo MM; Oshima M
    Cancer Res; 2015 Feb; 75(4):766-76. PubMed ID: 25687406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transposon mutagenesis identifies genes and evolutionary forces driving gastrointestinal tract tumor progression.
    Takeda H; Wei Z; Koso H; Rust AG; Yew CC; Mann MB; Ward JM; Adams DJ; Copeland NG; Jenkins NA
    Nat Genet; 2015 Feb; 47(2):142-50. PubMed ID: 25559195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15.
    Guo Y; Ayers JL; Carter KT; Wang T; Maden SK; Edmond D; Newcomb P P; Li C; Ulrich C; Yu M; Grady WM
    Aging Cell; 2019 Dec; 18(6):e13013. PubMed ID: 31389184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target.
    Zhao H; Ming T; Tang S; Ren S; Yang H; Liu M; Tao Q; Xu H
    Mol Cancer; 2022 Jul; 21(1):144. PubMed ID: 35836256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.
    Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
    J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence risk score: a multifaceted prognostic tool predicting outcomes, stemness, and immune responses in colorectal cancer.
    Zhang X; Huang Y; Li Q; Zhong Y; Zhang Y; Hu J; Liu R; Luo X
    Front Immunol; 2023; 14():1265911. PubMed ID: 37828981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of epigenetics in transformation of inflammation into colorectal cancer.
    Yang ZH; Dang YQ; Ji G
    World J Gastroenterol; 2019 Jun; 25(23):2863-2877. PubMed ID: 31249445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular pathways in colorectal cancer: apoptosis, autophagy and inflammation as key players.
    Yu L; Zhang MM; Hou JG
    Scand J Gastroenterol; 2022 Nov; 57(11):1279-1290. PubMed ID: 35732586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 increases expression of serine protease inhibitor Kazal type 1 through STAT3 in colorectal adenocarcinoma.
    Räsänen K; Lehtinen E; Nokelainen K; Kuopio T; Hautala L; Itkonen O; Stenman UH; Koistinen H
    Mol Carcinog; 2016 Dec; 55(12):2010-2023. PubMed ID: 26663388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
    Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
    Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Sleeping Beauty transposon-mediated screen identifies murine susceptibility genes for adenomatous polyposis coli (Apc)-dependent intestinal tumorigenesis.
    Starr TK; Scott PM; Marsh BM; Zhao L; Than BL; O'Sullivan MG; Sarver AL; Dupuy AJ; Largaespada DA; Cormier RT
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5765-70. PubMed ID: 21436051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZFR promotes cell proliferation and tumor development in colorectal and liver cancers.
    Long Y; Marian TA; Wei Z
    Biochem Biophys Res Commun; 2019 Jun; 513(4):1027-1034. PubMed ID: 31010678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel Targets.
    Penrose HM; Cable C; Heller S; Ungerleider N; Nakhoul H; Baddoo M; Hartono AB; Lee SB; Burow ME; Flemington EF; Crawford SE; Savkovic SD
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):391-408. PubMed ID: 30718226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation.
    Principe DR; DeCant B; Staudacher J; Vitello D; Mangan RJ; Wayne EA; Mascariñas E; Diaz AM; Bauer J; McKinney RD; Khazaie K; Pasche B; Dawson DW; Munshi HG; Grippo PJ; Jung B
    Oncotarget; 2017 Jan; 8(3):3826-3839. PubMed ID: 27270652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species and colorectal cancer.
    Lin S; Li Y; Zamyatnin AA; Werner J; Bazhin AV
    J Cell Physiol; 2018 Jul; 233(7):5119-5132. PubMed ID: 29215746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL1 promotes colon cancer progression through activation of NF-κB/P300 signaling pathway.
    Zhuo C; Ruan Q; Zhao X; Shen Y; Lin R
    Biol Direct; 2022 Nov; 17(1):34. PubMed ID: 36434686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.